Vertex Pharmaceuticals Incorporated
MODULATORS OF ALPHA-1 ANTITRYPSIN
Last updated:
Abstract:
Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).
Status:
Application
Type:
Utility
Filling date:
4 Oct 2019
Issue date:
17 Jun 2021